266 related articles for article (PubMed ID: 1175125)
1. A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
Huguley CM; Durant JR; Moores RR; Chan YK; Dorfman RF; Johnson L
Cancer; 1975 Oct; 36(4):1227-40. PubMed ID: 1175125
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy for stage IV Hodgkin's disease (Report no 14).
Goldman JM
Clin Radiol; 1981 Sep; 32(5):531-6. PubMed ID: 6168426
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
[TBL] [Abstract][Full Text] [Related]
4. Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation.
Br Med J; 1975 Aug; 3(5980):413-4. PubMed ID: 1098721
[TBL] [Abstract][Full Text] [Related]
5. Prednisone in MOPP chemotherapy for Hodgkin's disease.
Jacobs C; Portlock CS; Rosenberg SA
Br Med J; 1976 Dec; 2(6050):1469-71. PubMed ID: 1000259
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R
Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754
[TBL] [Abstract][Full Text] [Related]
7. Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy.
Krikorian JG; Portlock CS; Rosenberg SA
Cancer; 1978 Jun; 41(6):2107-11. PubMed ID: 77716
[TBL] [Abstract][Full Text] [Related]
8. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
Canellos GP
Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
[TBL] [Abstract][Full Text] [Related]
9. [Early results of combined treatment in Hodgkin's disease with nitrogen mustard, vincristine, Natulan and prednisone (MOPP treatment)].
Zelechowska JA; Madej G; Piemkowska F
Nowotwory; 1976; 26(3):163-70. PubMed ID: 980801
[No Abstract] [Full Text] [Related]
10. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
Aghai E; Kende G; Many A; Ramot B
Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045
[No Abstract] [Full Text] [Related]
11. Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP.
Bloomfield CD; Weiss RB; Fortuny I; Vosika G; Kennedy BJ
Cancer; 1976 Jul; 38(1):42-8. PubMed ID: 947533
[TBL] [Abstract][Full Text] [Related]
12. [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
Osieka R; Bruntsch U; Gallmeier WM; Seeber S; Schmidt CG
Dtsch Med Wochenschr; 1976 Aug; 101(32):1177-82. PubMed ID: 59661
[TBL] [Abstract][Full Text] [Related]
13. MOPP treatment of resistant Hodgkin's disease following ABVD failure.
Cimino G; Anselmo AP; Marzullo A; Maurizi Enrici R; Mauro F; Papa G; Mandelli F
Tumori; 1983 Oct; 69(5):469-72. PubMed ID: 6196891
[TBL] [Abstract][Full Text] [Related]
14. Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.
Santoro A; Viviani S; Villarreal CJ; Bonfante V; Delfino A; Valagussa P; Bonadonna G
Cancer Treat Rep; 1986 Mar; 70(3):343-8. PubMed ID: 2420444
[TBL] [Abstract][Full Text] [Related]
15. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
[TBL] [Abstract][Full Text] [Related]
16. Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse.
Fisher RI; DeVita VT; Hubbard SP; Simon R; Young RC
Ann Intern Med; 1979 May; 90(5):761-3. PubMed ID: 434676
[TBL] [Abstract][Full Text] [Related]
17. MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients.
Moore MR; Jones SE; Bull JM; William LA; Rosenberg SA
Cancer; 1973 Jul; 32(1):52-60. PubMed ID: 4716784
[No Abstract] [Full Text] [Related]
18. Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission.
Frei E; Luce JK; Gamble JF; Coltman CA; Constanzi JJ; Talley RW; Monto RW; Wilson HE; Hewlett JS; Delaney FC; Gehan EA
Ann Intern Med; 1973 Sep; 79(3):376-82. PubMed ID: 4748254
[No Abstract] [Full Text] [Related]
19. Combination chemotherapy in Hodgkin's disease: relation to radiotherapy.
Rosenberg SA
Bibl Haematol; 1975; (40):731-5. PubMed ID: 1164407
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy of advanced Hodgkin's disease. A review.
Goldsmith MA; Carter SK
Cancer; 1974 Jan; 33(1):1-8. PubMed ID: 4129559
[No Abstract] [Full Text] [Related]
[Next] [New Search]
